Oct. 08, 2024 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. (“Vivos” or the “Company”) (NASDAQ: VVOS), a medical technology company specializing in the development and commercialization of ...

VVOS Stock Movement on Tuesday VVOS stock is seeing heavy trading today alongside its CARE Medicare approval. That has more than 2.7 million shares changing hands as of this writing. This is well ...

Vivos Therapeutics (NASDAQ: VVOS), a leading medical device and technology company specializing in the development and commercialization of highly effective proprietary treatments for sleep ...

Vivos Therapeutics shares are trading lower by 25% Thursday morning. The company announced a $4.3 million registered offering.

(MENAFN- Investor Brand Network) Vivos Therapeutics (NASDAQ: VVOS) , a medical technology company specializing in the development and commercialization of highly effective proprietary treatments ...

Short interest in Vivos Therapeutics Inc (NASDAQ:VVOS) increased during the last reporting period, rising from 56.86K to 63.71K. This put 2.57% of the company's publicly available shares short.

The overall quant rating is not an average of the factor grades listed. Instead, it gives greater weight to the metrics with the strongest predictive value.

Elevate your confidence by analyzing investor sentiment and stock portfolio shifts, then make your own decisions.

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Investors may trade in the Pre-Market (4:00-9:30 a.m. ET) and the After Hours Market (4:00-8:00 p.m. ET). Participation from Market Makers and ECNs is strictly voluntary and as a result, these ...

Oct. 08, 2024 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. (“Vivos” or the “Company”) (NASDAQ: VVOS), a medical technology company specializing in the development and commercialization of highly ...